Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
Clinical trial NCT05910476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05910476
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2026-09-22
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.